Weilin Xia

Weilin Xia


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
GLGengcong Luo
Gengcong Luo
CXChen Xitian
Chen Xitian
YLYongqing Li
Yongqing Li
HJHongbin Jiang
Hongbin Jiang
SLShu Liu
Shu Liu
WXWeilin Xia
Weilin Xia
PD-1 inhibitors have reshaped the treatment landscape of relapsed or refractory classic Hodgkin lymphoma (r/r cHL), yet validated biomarkers in this settin